Clinical Trials
5 trialsNCT07121322 2025-08-13
DACT-GCT
National Cancer Institute, Slovakia
Phase 2 Recruiting
NCT03950830 2023-10-04
DISGCT
National Cancer Institute, Slovakia
Phase 2 Completed
NCT02414685 2020-08-07
TIP
National Cancer Institute, Slovakia
Phase 2 Completed
NCT03403777 2019-03-05
Avelumab in Refractory Testicular Germ Cell Cancer.
National Cancer Institute, Slovakia
Phase 2 Completed
NCT01466231 2016-01-12
Everolimus in Refractory Testicular Germ Cell Cancer
National Cancer Institute, Slovakia
Phase 2 Completed